Filing Details
- Accession Number:
- 0001209191-23-017020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-07 21:19:09
- Reporting Period:
- 2023-03-06
- Accepted Time:
- 2023-03-07 21:19:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 70318 | Tenet Healthcare Corp | THC | Services-General Medical & Surgical Hospitals, Nec (8062) | 952557091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1852128 | W Thomas Arnst | 14201 Dallas Parkway Dallas TX 75254 | Evp, Chief Admin. Officer & Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-06 | 4,213 | $0.00 | 4,213 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-06 | 1,658 | $60.62 | 2,555 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-03-06 | 3,869 | $0.00 | 6,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-06 | 1,523 | $59.29 | 4,901 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-03-06 | 5,531 | $0.00 | 10,432 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-06 | 2,177 | $58.53 | 8,255 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-03-06 | 21,125 | $0.00 | 29,380 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-06 | 5,777 | $58.53 | 23,603 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-03-06 | 825 | $61.00 | 22,778 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | 2022 February Restricted Stock Units | Disposition | 2023-03-06 | 4,213 | $0.00 | 4,213 | $0.00 |
| Common Stock | 2021 February Restricted Stock Units | Disposition | 2023-03-06 | 3,869 | $0.00 | 3,869 | $0.00 |
| Common Stock | 2020 February Restricted Stock Units | Disposition | 2023-03-06 | 5,531 | $0.00 | 5,531 | $0.00 |
| Common Stock | 2020 February Performance-Based Restricted Stock Units | Disposition | 2023-03-06 | 21,125 | $0.00 | 21,125 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,427 | No | 4 | M | Direct | ||
| 4,156 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023.
- Restricted stock units convert into common stock on a one-for-one basis.
- The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the vesting and settlement of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan.
- Represents the closing price of the common stock of the Issuer on the vesting date.
- The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023.
- The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, vest equally in one-third increments on February 28, 2021, February 28, 2022 and February 28, 2023, and the third and final 1/3 increment settled on March 6, 2023.
- On June 2, 2020, the reporting person received a target grant of 16,594 performance-based restricted stock units, scheduled to vest on February 28, 2023, subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 21,125 units. The performance-based restricted stock units settled on March 6, 2023.
- The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.01. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock.
- The amount of performance-based restricted stock units received reflects a prior transfer of performance-based restricted stock units to the former spouse of the Reporting Person in accordance with the terms of a divorce agreement.
Billionaire Hedge Funds
